MEHRAD ADIBI to United States
This is a "connection" page, showing publications MEHRAD ADIBI has written about United States.
Connection Strength
0.014
-
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial. Lancet Oncol. 2020 06; 21(6):776-785.
Score: 0.014